The teal ribbon, pictured above, is used to represent the Fight Against Ovarian Cancer
I am back to my favorite Qmed today. They led me to a neat article on MIT News.
Ovarian cancer, while rare, still affects a number of women. According to the National Cancer Institute (NCI – link below), approximately 1.3 % of women will be diagnosed to cancer during their lifetime, and in 2014, they approximated that 222,060 women were living with Ovarian Cancer in the United States.
In addition, as detailed both in the Qmed Article and MIT News (links below), Ovarian Cancer detection is challenging, and usually detection doesn’t occur well after the disease has reached a certain size.
Consequently, this represents an important challenge in healthcare, and with the support of some much needed funding and the investment of great scientific minds, MIT might have used synthetic biomarkers, that, if transferred successfully from the current mouse models to humans, can shave diagnostics time by about 5 months! And five months, can definitely mean a lot for disease detection, treatment and/or management.
Read more about synthetic biomarkers, the challenges with Ovarian Cancer detection, and other interesting information through the links below.
- The Qmed Article: http://www.qmed.com/mpmn/medtechpulse/better-way-find-ovarian-cancer?cid=nl.x.qmed02.edt.aud.qmed.20170503
- The MIT News Article: http://news.mit.edu/2017/new-technology-detect-tiny-ovarian-tumors-0410
- Some NCI stats on Ovarian Cancer: https://seer.cancer.gov/statfacts/html/ovary.html